{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3456, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "analyze_data", "notes": "The chart shows dose-response curves for cell binding. The table summarizes EC50 values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/19", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "other", "function": "analyze_data", "notes": "The chart shows a biphasic exponential decay curve for three datasets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/20", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "other", "function": "analyze_data", "notes": "The chart uses a regression line to correlate human and NHP half-lives, highlighting the 3.1x multiplier for YTE-modified antibodies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/21", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a visual timeline/comparison to contrast the high injection frequency of the competitor with the lower frequency of SPY001.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/22", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "problem_statement", "function": "frame_problem", "notes": "The chart combines a bar chart of competitor benchmarks with a bar chart showing vedolizumab's exposure-response quartiles.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/23", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Data from GEMINI 1 study; compares Q8W and Q4W dosing regimens.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/24", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "executive_summary", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/25", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "timeline", "function": "size_opportunity", "notes": "The slide uses a dual-axis approach: a bar chart for valuation benchmarks and a timeline for clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/26", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a visual pipeline format to track progress from Discovery to Clinical stages for specific drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/27", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "key_takeaways", "function": "compare_peers", "notes": "The chart compares clinical remission rates across different drug classes (TL1A, a4b7, IL-23s, TNFas, S1P1s, JAKs) with a safety gradient indicated on the Y-axis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/28", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Uses a checkmark matrix to highlight competitive advantages of SPY002.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/29", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses an antibody diagram to annotate specific technical advantages of the SPY002 molecule.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/30", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a bar chart to compare efficacy and provides a strategic rationale for pursuing both monomeric/trimeric and trimeric-only approaches.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/31", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_takeaways", "function": "compare_peers", "notes": "Includes two charts: a dose-response curve and a scatter plot of potency vs. binding specificity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/32", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "key_takeaways", "function": "compare_peers", "notes": "The table contrasts established drugs (with confirmed exposure-response) against newer anti-TL1A agents (PRA023, RVT-3101) where this relationship is currently TBD.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/33", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "executive_summary", "function": "present_solution", "notes": "The slide uses a 2x2 grid to summarize program strengths and a timeline for catalysts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/34", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "other", "function": "present_solution", "notes": "The slide uses a mountain-climbing metaphor to represent indication expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/35", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the progress of various drug candidates (SPY001-SPY230).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/36", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "other", "function": "present_solution", "notes": "The slide uses a biological process diagram to illustrate drug targets (a4b7, TL1A, IL-23) and their corresponding therapeutic antibodies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/37", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a bar chart to illustrate additive clinical remission rates, with a table below providing additional clinical metrics (N, maintenance remission, safety).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/38", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses donut charts to represent remission rates and highlights the safety advantages of Spyre's gut-selective approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/39", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "roadmap", "function": "plan_implementation", "notes": "Includes a specific note that this is an 'Illustrative example' and 'Preliminary; pending regulatory feedback'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/40", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a bispecific antibody illustration to represent the combination therapy approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/41", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "problem_statement", "function": "present_solution", "notes": "The slide uses a Venn diagram to illustrate target overlap and a hierarchical tree to show potential combination therapy paths.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/42", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "key_takeaways", "function": "illustrate_case", "notes": "The slide uses a comparative bar chart structure to show the delta in efficacy when using a companion diagnostic (CDx).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/43", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/44", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "team_bio", "function": "other", "notes": "The slide displays headshots of leadership and board members, followed by a grid of company logos representing their backgrounds or affiliations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/45", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table-based timeline format to track R&D progress and external data readouts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/46", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table uses a custom visualization for market cap range (min, IPO, today, max) and clinical stage progression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/47", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table maps historical industry M&A deals to Spyre's internal pipeline development milestones (2025-2027).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/48", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/49", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-49", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-12bd-74a7-bc75-4587e4948a57", "docSlug": "9c54f748d4238e6a3a690a4101a45e99", "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "executive_summary", "function": "establish_context", "notes": "The slide uses a list-based format to highlight key organizational milestones and metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/50", "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57", "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-50", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/bqs2OXcyPmC_3HiEiL0I-sUTjxQ445QWqOxU-A60u14/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZmUyODY1YWRlZmQ0ZTYyNzM1N2Y1YzA4MDY1OGFiYS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/1", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/Be6MM_PgB-BAKe0CWntAoj-iKbMR5tLDIPiFyzTspJQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZmUyODY1YWRlZmQ0ZTYyNzM1N2Y1YzA4MDY1OGFiYS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/MA-lQ4R4GtVbhQ1i27hr7Txn91VYFn9_iaHVbiWzMTw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZmUyODY1YWRlZmQ0ZTYyNzM1N2Y1YzA4MDY1OGFiYS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/AvyAtFQ5j2Ou_VMwuqWf9bIiAMPUQlmLaBqq4_1J4RI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZmUyODY1YWRlZmQ0ZTYyNzM1N2Y1YzA4MDY1OGFiYS9wMDAxLnBuZw" }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": "Includes company overview, forward-looking statement safe harbor, SEC filing information, non-GAAP definition, and trademark disclosures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/2", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/3", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/4", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "11d99372-f0f0-424e-bb3a-bf91dc8ef04e", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 4-7 highlight Alkermes' transformation and current state.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "executive_summary", "function": "summarize", "notes": "This is a classic 'preempt_rebuttal' style slide used in proxy contests to defend the incumbent board.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/5", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "11d99372-f0f0-424e-bb3a-bf91dc8ef04e", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 4-7 highlight Alkermes' transformation and current state.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/6", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "11d99372-f0f0-424e-bb3a-bf91dc8ef04e", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 4-7 highlight Alkermes' transformation and current state.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a four-column layout to summarize key business pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/7", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "11d99372-f0f0-424e-bb3a-bf91dc8ef04e", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Current Reality (Pain)", "beatSlug": "transformation-tale-current-reality-pain", "evidence": "Slides 4-7 highlight Alkermes' transformation and current state.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-column layout to present strategic priorities, with a footer highlighting stock performance relative to peers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/8", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "97ef35fc-ef4f-4e9e-bce2-40e57dc8a0d5", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 8-12 outline Alkermes' strategic priorities and growth prospects.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/9", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "97ef35fc-ef4f-4e9e-bce2-40e57dc8a0d5", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 8-12 outline Alkermes' strategic priorities and growth prospects.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "before_after", "function": "summarize", "notes": "The slide uses a numbered list format to map strategic pillars to specific results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/10", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-10", "loopMatches": [ { "to": 13, "from": 10, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "e8d385b8-c821-443e-9073-142efbad8b86", "evidence": "Slides 10-13 show the before-after impact of the refreshed board.", "position": 0, "objective": "Highlight the positive impact of Alkermes' refreshed board on shareholder value", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "97ef35fc-ef4f-4e9e-bce2-40e57dc8a0d5", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 8-12 outline Alkermes' strategic priorities and growth prospects.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses three bar charts to demonstrate superior performance of ALKS relative to benchmarks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/11", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-11", "loopMatches": [ { "to": 13, "from": 10, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "e8d385b8-c821-443e-9073-142efbad8b86", "evidence": "Slides 10-13 show the before-after impact of the refreshed board.", "position": 0, "objective": "Highlight the positive impact of Alkermes' refreshed board on shareholder value", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "97ef35fc-ef4f-4e9e-bce2-40e57dc8a0d5", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 8-12 outline Alkermes' strategic priorities and growth prospects.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses bar charts to demonstrate performance relative to an 'unaffected date' related to a shareholder activist event.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/12", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-12", "loopMatches": [ { "to": 13, "from": 10, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "e8d385b8-c821-443e-9073-142efbad8b86", "evidence": "Slides 10-13 show the before-after impact of the refreshed board.", "position": 0, "objective": "Highlight the positive impact of Alkermes' refreshed board on shareholder value", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "97ef35fc-ef4f-4e9e-bce2-40e57dc8a0d5", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "Slides 8-12 outline Alkermes' strategic priorities and growth prospects.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "before_after", "function": "analyze_data", "notes": "The slide highlights a 50% improvement in valuation multiple despite a decline in the NBI index multiple.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/13", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-13", "loopMatches": [ { "to": 13, "from": 10, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "e8d385b8-c821-443e-9073-142efbad8b86", "evidence": "Slides 10-13 show the before-after impact of the refreshed board.", "position": 0, "objective": "Highlight the positive impact of Alkermes' refreshed board on shareholder value", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "testimonial", "function": "cite_precedent", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/14", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": "The slide highlights board changes, including specific appointments with shareholder support and the addition of diverse skill sets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/15", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "timeline", "function": "expose_contradiction", "notes": "The slide uses a dual-axis timeline (top and bottom) to annotate events on a stock price chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/16", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "comparison_table", "function": "analyze_data", "notes": "The table categorizes products into 'Proprietary' and 'Royalty' streams.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/17", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-17", "loopMatches": [ { "to": 20, "from": 17, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "8c753e0f-bc7c-4296-afd3-cccb0d4a6d82", "evidence": "Slides 17-20 provide a MECE breakdown of Alkermes' growth and profitability.", "position": 1, "objective": "Break down Alkermes' growth and profitability drivers", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a mix of bar charts for annual revenue and a line chart for weekly prescription growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/18", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-18", "loopMatches": [ { "to": 20, "from": 17, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "8c753e0f-bc7c-4296-afd3-cccb0d4a6d82", "evidence": "Slides 17-20 provide a MECE breakdown of Alkermes' growth and profitability.", "position": 1, "objective": "Break down Alkermes' growth and profitability drivers", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a bar chart to show quarterly net sales growth from Q4'21 to Q1'23.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/19", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-19", "loopMatches": [ { "to": 20, "from": 17, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "8c753e0f-bc7c-4296-afd3-cccb0d4a6d82", "evidence": "Slides 17-20 provide a MECE breakdown of Alkermes' growth and profitability.", "position": 1, "objective": "Break down Alkermes' growth and profitability drivers", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses donut charts to represent revenue composition and growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/20", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-20", "loopMatches": [ { "to": 20, "from": 17, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "8c753e0f-bc7c-4296-afd3-cccb0d4a6d82", "evidence": "Slides 17-20 provide a MECE breakdown of Alkermes' growth and profitability.", "position": 1, "objective": "Break down Alkermes' growth and profitability drivers", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 20, "from": 13, "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "before_after", "function": "present_solution", "notes": "Uses a before-after comparison of drug development stages (Gantt-style pipeline).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/21", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/22", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a break in the x-axis to transition from historical data (2020-2022) to future projections (2024-2025).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/23", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "timeline", "function": "illustrate_case", "notes": "The slide uses a chronological sequence to demonstrate management's effective handling of a major revenue threat.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/24", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "other", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram to show the core Alkermes business and a separate branch for the oncology spin-off.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/25", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "other", "function": "frame_situation", "notes": "The slide uses a two-column layout to contrast the board's strategic rationale with the specific value propositions of the resulting companies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/26", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/27", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-1362-766d-ac60-1333cab868aa", "docSlug": "7fe2865adefd4e627357f5c080658aba", "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "team_bio", "function": "introduce_nominees", "notes": "The slide uses a grid layout with headshots, biographical bullet points, and committee membership indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/28", "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa", "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }